MediciNova

MediciNova develops ibudilast (MN-166) for progressive multiple sclerosis, amyotrophic lateral sclerosis, chemotherapy-induced peripheral neuropathy, and glioblastoma, and tipelukast (MN-001) for nonalcoholic fatty liver disease and hypertriglyceridemia.